Treatment
Treatment clinical trials
We’re tracking 8,479 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07069127Recruiting
Home treatment for tooth sensitivity in celiac disease
This study tests a special toothpaste-like treatment for adults with celiac disease who have sensitive teeth and enamel problems. You apply it at home, and it may help reduce tooth pain and protect your teeth.
Pavia, LombardyAges 18 years+ - NCT07069517Recruiting
Fast treatment for insomnia, nightmares, and PTSD
This study tests a combined program to help active-duty military and veterans with PTSD, insomnia, and nightmares. It aims to see if a short treatment can improve sleep and reduce PTSD symptoms without starting new medications or other therapies.
Kileen, TexasAges 18–65 - NCT07069712RecruitingPhase 2
New drug combos before and after surgery for stomach or esophageal cancer
This trial is testing new drug combinations given before and after surgery for stomach or esophageal cancer that can be removed. The goal is to see if these treatments work better than standard care. You may be eligible if your tumor has certain markers and you haven't had treatment for this cancer yet.
Newark, DelawareAges 18 years+ - NCT07069790Recruiting
Chemotherapy effects on body reflexes after breast cancer treatment
This study looks at how chemotherapy affects the body's automatic reflexes, like heart rate and blood pressure control. It compares women who recently finished chemo for breast cancer with healthy women to understand side effects and recovery.
StrasbourgAges 18 years+ - NCT07070583Recruiting
Effect of Leg Artery Blockage Treatment on Blood Pressure
This study looks at how treating blocked arteries in the lower belly and groin area affects blood pressure. If you have a long blockage in your main artery or the arteries to your legs that causes pain or trouble walking, this trial may help understand if treatment improves your blood pressure.
ArnhemAges 18 years+ - NCT07070765Recruiting
Study on dapagliflozin to protect the heart during breast cancer chemo
This trial tests if a heart-protecting drug called dapagliflozin can help prevent heart damage in breast cancer patients receiving a type of chemotherapy called anthracycline. It may be an option if you have low to medium heart risk factors.
Aberdeen, AberdeenshireAges 18–70 - NCT07070648Recruiting
Predicting DLBCL treatment response with ctDNA and PET scans
This trial uses a blood test (ctDNA) and PET scans to predict how well standard first-line treatment works for diffuse large B-cell lymphoma (DLBCL). It aims to find out if these tests can guide better care.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07071038RecruitingPhase 2
Switching medication to relieve side effects from aromatase inhibitors
This trial tests whether switching to a different aromatase inhibitor or using standard treatments works better for managing side effects in breast cancer survivors. It aims to help you stay on hormone therapy longer with fewer discomforts.
Lebanon, New HampshireAges 18 years+ - NCT07071350RecruitingPhase 2/Phase 3
Optimizing heart rate for persistent concussion symptoms in military veterans
This trial tests a treatment designed to improve heart rate variability, which may help reduce long-term concussion symptoms like headaches, dizziness, and trouble sleeping. It is for military veterans who have had a mild concussion more than a year ago and still have ongoing symptoms.
Richmond, VirginiaAges 18 years+ - NCT07072208Recruiting
A Study of Four Drugs for Older Adults with DLBCL
This trial tests a combination of four medications (pomalidomide, rituximab, orelabrutinib, and polatuzumab vedotin) for newly diagnosed, elderly patients with diffuse large B-cell lymphoma (DLBCL) who cannot tolerate standard treatments. It aims to see if this combination is effective and safe for older adults.
Suzhou, JiangsuAges 70 years+ - NCT07072247RecruitingPhase 1
RN1201 injection for hard-to-treat antibody-mediated blood disorders
This trial tests a new injection called RN1201 for people with antibody-mediated diseases, specifically two types of blood disorders: platelet transfusion refractoriness (PTR) and immune thrombocytopenia (ITP) that haven't responded to standard treatments. The goal is to see if RN1201 can help control these conditions.
Suzhou, JiangsuAges 16–65 - NCT07072234RecruitingPhase 1
CAR NK cell therapy for advanced clear cell kidney cancer
This trial tests a new type of immune cell therapy (CAR NK cells) that targets a protein called CD70 on kidney cancer cells. It's for people with advanced clear cell kidney cancer that hasn't responded to standard treatments.
Houston, TexasAges 18 years+ - NCT07072351RecruitingPhase 1/Phase 2
Radiation plus chemoimmunotherapy for gastroesophageal junction cancer
This trial tests a shorter course of radiation combined with chemotherapy and immunotherapy to shrink gastroesophageal junction cancer before surgery. It aims to make the tumor removable and improve outcomes.
Xiamen, FujianAges 18 years+ - NCT07072364Recruiting
Videos to help decide on fibroid treatment
This study tests if watching short videos helps people with uterine fibroids make better treatment decisions with their doctor. You are eligible if you have fibroids and are scheduled to discuss options at a Penn Medicine clinic.
Philadelphia, PennsylvaniaAges 18–55 - NCT07072832Recruiting
3D printed implant for hip dysplasia pain
This trial tests a new treatment for adults with hip dysplasia (a shallow hip socket) using a custom 3D-printed implant to reshape the socket. It's for people with groin pain or trouble walking who haven't had previous hip surgery after age 10 and have minimal arthritis.
GeldropAges 18–45 - NCT07073846RecruitingPhase 4
Lidocaine and dexmedetomidine for pain after weight-loss surgery
This study tests whether adding two medicines (lidocaine and dexmedetomidine) to your anesthesia during weight-loss surgery can reduce pain, swelling, and stress on the body. It might help you have a smoother recovery.
Mexico City, Mexico CityAges 18–60 - NCT07074470Recruiting
New drug combo for relapsed brain lymphoma
This trial tests a new combination of drugs (teniposide, a PD-1 checkpoint inhibitor, and selinexor) for people with relapsed or refractory primary central nervous system lymphoma. It aims to see if this three-drug approach can shrink tumors or slow the disease when previous treatments haven't worked.
Suzhou, JiangsuAges 18–75 - NCT07074444RecruitingPhase 4
Treating clonorchiasis with three different drugs
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
Nanning, GuangxiAges 18 years+ - NCT07074756Recruiting
Digital home treatment program for glioma patients
This trial tests a digital platform that helps you follow a treatment plan at home, alternating between two different drug regimens, to see if it helps people with glioma live longer and feel better. It is designed for patients who need ongoing systemic therapy (chemotherapy or targeted drugs) for at least six months.
Jacksonville, FloridaAges 18 years+ - NCT07074951Recruiting
Tonsillectomy and immune therapy for high-risk IgA kidney disease
This trial tests whether removing the tonsils (tonsillectomy) plus immune-suppressing therapy can help people with a high-risk form of IgA nephropathy, a kidney disease. It aims to slow down kidney damage and delay the need for dialysis.
Saint PetersburgAges 18–75 - NCT07076004Recruiting
Nutrition support for cancer patients in Maine
This study looks at how nutrition support can help people with cancer. If you live in certain counties in Maine and have ever been diagnosed with cancer, you may be able to join a program that provides healthy food and guidance.
New Haven, ConnecticutAges 18 years+ - NCT07076472RecruitingEarly Phase 1
Sound and drug therapy for recurrent glioblastoma
This trial tests a new approach that combines a drug (SONALA-001 or 5-ALA) with focused ultrasound to treat glioblastoma that has come back or is growing despite standard treatments. The drug makes tumor cells sensitive to sound waves, and the ultrasound waves are directed at the tumor using MRI guidance. This may help damage cancer cells while sparing healthy brain tissue.
Rochester, MinnesotaAges 18 years+ - NCT07076498RecruitingPhase 1
Gene therapy for children and adults with diffuse midline glioma
This trial tests a modified herpes virus (M032) given directly into the brain tumor after standard radiation. The goal is to see if this virus can slow or stop the growth of diffuse midline glioma, a type of brain cancer.
Houston, TexasAges 3 years+ - NCT07077044Recruiting
Testing nerve stimulation for kids with constipation
This study tests a new treatment for children with long-lasting constipation that hasn't improved with standard care. It compares nerve stimulation (TTNS with or without a special device called PHUS) against usual therapy to see which works best.
JerusalemAges 4–14
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,479 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.